Related Experiment Video
Updated: Jul 19, 2026

Intracoronary Acetylcholine Provocation Testing for Assessment of Coronary Vasomotor Disorders
Published on: August 18, 2016
Chest pain: an update
Mats Börjesson1, Clas Mannheimer
1Multidisciplinary Pain Center, Department of Medicine, Sahlgrenska University Hospital/Ostra, Göteborg, Sweden. mats.brjesson@telia.com
Insights
Chest pain units can help quickly identify acute coronary syndromes and rule out myocardial ischemia. This approach aids in managing chest pain patients effectively, considering various causes beyond cardiac issues.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Diagnostics
Background:
- Chest pain is a frequent reason for emergency medical care, but diagnosing myocardial ischemia is challenging and costly.
- Effective strategies are needed to assess ischemia risk and avoid unnecessary hospitalizations for chest pain patients.
Purpose of the Study:
- To review recent advancements in chest pain evaluation and diagnosis.
- To discuss the role of chest pain units in identifying high-risk patients for acute coronary syndromes.
- To consider alternative cardiac and non-cardiac causes of chest pain.
Main Methods:
- Review of recent developments in triage and ischemia detection methods for chest pain.
- Discussion of various causes of chest pain, including esophageal, drug-related, psychiatric, and post-coronary bypass surgery pain.
- Examination of findings related to Syndrome X and myocardial infarction presentation without chest pain.
Main Results:
- Triage and various detection methods aid in ruling in or out ischemic pain.
- Non-ischemic causes like esophageal dysfunction, drugs, and post-surgical pain are significant considerations.
- Syndrome X and atypical presentations of myocardial infarction are also relevant findings.
Conclusions:
- Point-of-care biochemical analyses may enable rapid and safe exclusion of myocardial ischemia.
- Biopsychosocial factors, pain perception, and specific procedures influence chest pain management.
- Clinical strategies for handling chest pain patients can be improved by considering these diverse factors.
Purpose Of Review:
Chest pain is one of the most common symptoms for seeking acute medical care. Evidence of myocardial ischemia, however, can only be established in a minority of patients. The establishment or ruling out of myocardial ischemia is difficult and the cost is high. An effective rationale for ischemia detection, without unnecessary hospital admission, is needed. The development of chest pain units potentially offers a rapid, effective way of identifying patients at high risk for acute coronary syndromes, as well as those with a low probability of ischemia. Other cardiac or noncardiac causes of chest pain should also be considered.
Recent Findings:
Recent developments in chest pain, including the ruling in or out of ischemic pain by triage and different ischemia detection methods, are discussed. Other causes of chest pain such as esophageal, drug related, psychiatric and post-coronary bypass surgery pain are also discussed. Recent findings on syndrome X are reviewed and patients with myocardial infarction presenting without chest pain are discussed.
Summary:
The possibility of safely and quickly ruling out myocardial ischemia by point-of-care biochemical analyses is reviewed, which might influence our clinical handling of chest pain patients. The importance of biopsychosocial factors, pain perception, esophageal dysfunction, drugs and the coronary artery bypass procedure in itself, is discussed and vital clinical information is provided for the handling of our chest pain patients.
Related Concept Videos
Angina III: Clinical Manifestations and Assessment
Angina V: Nursing Management
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Angina II: Classification
Angina I: Introduction
Coronary Artery Disease III: Clinical Manifestations

